Immunopeptidome profiling in pulmonary fibrosis: linking antigenicity to cytotoxic immunity and therapeutic targeting. [PDF]
Karampitsakos T +2 more
europepmc +1 more source
Pulmonary parenchyma becomes a self-organized dissipative structure in lung cancers and pulmonary inflammatory diseases. [PDF]
Lecarpentier Y +7 more
europepmc +1 more source
An NFATC4 phospho-switch links matrix stiffness to fibroblast fate. [PDF]
Frabotta RS, Tata PR.
europepmc +1 more source
Targeted depletion of activated fibroblasts via [<sup>177</sup>Lu]Lu-FAPI radionuclide therapy ameliorates bleomycin-induced lung fibrosis. [PDF]
Sun L +5 more
europepmc +1 more source
Multiple triggering mechanisms of myocardial fibrosis: Comparison and integration in different disease contexts. [PDF]
Zhao B +7 more
europepmc +1 more source
Fibrosis as the Engine of Kidney Functional Decline: Donald W. Seldin Young Investigator Award Lecture. [PDF]
Koch L, Dilmen E, Jansen J, Kramann R.
europepmc +1 more source
Organelle Crosstalk and Metabolic Reprogramming in Idiopathic Pulmonary Fibrosis: Mechanisms and Therapeutic Implications. [PDF]
Zhang Y, Teng L, Gong L, Fu Y, Qian M.
europepmc +1 more source
Contribution of Cardiac CD34⁺ Stromal Cells to Post-Myocardial Infarction Repair in Middle-Aged Rats. [PDF]
Schneider DT, Dedkov EI.
europepmc +1 more source
Autocrine SFRP2 (secreted frizzled related protein 2) enhances lung myofibroblast fibrogenic activity by suppressing PINK1-mediated mitophagy initiation. [PDF]
Lin Y +7 more
europepmc +1 more source
PW1<sup>+</sup> cells give rise to cardiac adipocytes during development and myofibroblasts following injury. [PDF]
Wei Y +9 more
europepmc +1 more source

